chartexchange

CTXR
Citius Pharmaceuticals Inc. Common
stockNASDAQ

At CloseNov 18, 2026 3:56:50 PM EST
0.51USD-1.484%(-0.01)68,049
After-hoursNov 18, 2026 4:00:30 PM EST
0.5107USD-0.078%(-0.0004)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Myron Holubiak
HQ
Cranford, NJ, USA
Previous Close
$0.52
Beta
1.99
52-Week High
$1.54 2025-11-26
52-Week Low
$0.37 2026-10-22
SMA 50
$0.52
SMA 200
$0.64
Avg. Vol 10D
254,159
Avg. Vol 30D
264,964
Avg. Vol 90D
456,960
Relative Vol
0.26
26.96M
83.0300%
127,288
Dec 22, 2026 (33d)
Nov 26, 2024 · 1-for-25 (reverse)
CTXR Profile

citius pharmaceuticals, inc., a specialty pharmaceutical company, develops and commercializes critical care products. it primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. the company is developing mino-lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in phase iii clinical trials; mino-wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; halo-lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and novecite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. citius pharmaceuticals, inc. was founded in 2007 and is headquartered in cranford, new jersey.

CTXR Performance
PeriodPriceDateChangeBeta
1W0.482026-11-11+6.32%4.843
1M0.432026-10-19+19.44%0.209
3M0.572026-08-18-10.64%0.564
6M0.532026-05-18-3.05%1.205
1Y1.072025-11-18-52.25%1.992
2Y5.612024-11-18-90.88%—
5Y42.252021-11-18-98.79%1.110
CTXR Stock Summary

Citius Pharmaceuticals Inc. Common (NASDAQ:CTXR) stock price today is $0.51, and today's volume is 68,049. CTXR is down 1.513% today. The 30 day average volume is 264,964. CTXR market cap is $14.03M with 27.45M shares outstanding.